Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Moderna, Inc. MRNA

Healthcare  —  Biotechnology
198.88 4.06 2.08% as of 25 Sep
Market cap
$78.8B
P/E
0.0×
S&P 500 Member
Indexes indicate stock being part of an index
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Moderna, Inc. (MRNA) EV/Sales

As of 25 September 2026, Moderna, Inc. (MRNA) trades at a EV/Sales of 33.5×. Over the past ten years it has ranged from −2.6× (January 2019) to 521× (May 2020); the current reading is higher than 76% of that period. That is above the Biotechnology industry median of 10.7× and above the Healthcare sector median of 3.6×.

EV/Sales, daily

Annual

Period EV/Sales Change
FY2025 3.2× 16.45%
FY2024 2.8× (45.62%)
FY2023 5.1× 59.76%
FY2022 3.2× (36.02%)
FY2021 5.0× (88.64%)
FY2020 44.0× (51.23%)
FY2019 90.2× —
FY2018 −2.1× —
FY2017 0.0× —
FY2016 0.0× —

Quarterly

Period EV/Sales Change
Jun 2026 10.5× 50.67%
Mar 2026 7.0× 115.05%
Dec 2025 3.2× 28.91%
Sep 2025 2.5× 37.65%
30 more quarters

Against its own ten years

Low −2.6× High 521×
Ten-year median 4.8×
Current reading's percentile 76

EV/Sales against peers

Company EV/Sales
REGN Regeneron Pharmaceuticals, Inc. compare 4.9×
ONC BeOne Medicines Ltd. - Sponsored ADR compare 6.0×
ALNY Alnylam Pharmaceuticals, Inc. compare 6.6×
VRTX Vertex Pharmaceuticals Incorporated compare 10.0×
ARGX argenex SE compare 10.5×
RPRX Royalty Pharma PLC compare 13.4×
INSM Insmed, Inc. compare 22.2×
MRNA Moderna, Inc. 33.5×
RVMD Revolution Medicines, Inc. compare 1,499×
Biotechnology industry median 10.7×
Healthcare sector median 3.6×
Market median 2.2×

What EV/Sales is

EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)

The full definition of EV/Sales →

More on MRNA